Lataa...
4CPS-040 Cost-comparison of secukinumab and ustekinumab for treatment of psoriasis
BACKGROUND: Secukinumab is a monoclonal antibody designed to recognise and attach to a messenger molecule in the immune system called interleukin 17A, whereas ustekinumab is also a monoclonal antibody which attaches to two cytokines called interleukin 12 and interleukin 23. All these cytokines are i...
Tallennettuna:
| Julkaisussa: | Eur J Hosp Pharm |
|---|---|
| Päätekijät: | , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMJ Group
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535608/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.131 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|